Attovia Therapeutics, Inc. (ATTO)
13.83
-0.67
(-4.62%)
USD |
NASDAQ |
Oct 23, 16:00
13.83
0.00 (0.00%)
After-Hours: 20:00
Attovia Therapeutics EPS Diluted (Quarterly) : -0.4532 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4532 |
| March 31, 2026 | -0.4087 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.3163 |
| March 31, 2025 | -0.3378 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.69M |
| Revenue (Quarterly) | 0.45M |
| Total Expenses (Quarterly) | 21.14M |
| Enterprise Value | 778.78M |
| Gross Profit Margin (Quarterly) | 45.33% |
| Profit Margin (Quarterly) | -4.60K% |
| Earnings Yield | -10.96% |
| Normalized Earnings Yield | -10.94 |